: Highlighted for its healthy 4.6% dividend yield and its early lead in the race to launch 5G connectivity.
: Analysts favored it after breakthrough clinical trials for its cystic fibrosis treatment promised to triple its revenue by 2021. 10 stocks to buy in 2017
: Seen as being at an "inflection point" where its transition to a cloud-based, subscription revenue model via Azure and Office was finally starting to boost margins. : Highlighted for its healthy 4
AI responses may include mistakes. For financial advice, consult a professional. Learn more 10 large-cap stocks to consider for 2017 - CBS News 10 stocks to buy in 2017
: A "best way to play" the memory chip trend, benefiting from high demand and rising prices for DRAM and NAND used in mobile devices and servers.
You must be logged in to post a comment.